- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Regorafenib – July 2014
Regorafenib, tablet, 40 mg, Stivarga®, Bayer Australia Limited
Last updated
8 November 2023